MILD TO MODERATE HYPERTENSION
Clinical trials for MILD TO MODERATE HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new MILD TO MODERATE HYPERTENSION trials appear
Sign up with your email to follow new studies for MILD TO MODERATE HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for high blood pressure shows promise in japanese study
Disease control CompletedThis study tested an experimental drug called zilebesiran in 36 Japanese adults with mild to moderate high blood pressure. The goal was to see if it is safe and helps lower blood pressure over 6 months. Participants received either the drug or a placebo, and researchers monitored…
Matched conditions: MILD TO MODERATE HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New injection shows promise for controlling high blood pressure
Disease control CompletedThis study tested a new medicine called ALN-AGT01 in 394 adults with mild-to-moderate high blood pressure. The goal was to see if it could safely lower blood pressure over three months. Participants received either the drug or a placebo, and blood pressure was measured continuous…
Matched conditions: MILD TO MODERATE HYPERTENSION
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC